share_log
Moomoo 24/7 ·  03/11 07:47

Sonnet BioTherapeutics Shares Are Trading Higher After the Company's Phase 1b/2a Clinical Trial of SON-080 Was Cleared to Proceed to Phase 2 After Review by an Independent DSMB

Sonnet BioTherapeutics股价走高,此前该公司的 SON-080 1b/2a期临床试验经独立DSMB审查后获准进入第二阶段

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发